Company News

Good Start for Work | Conlead Pharmaceutical Awarded Title of "Hangzhou Innovative Small and Medium-Sized Enterprise"

Release time：2025-02-05

Recently, the Hangzhou Municipal Bureau of Economy and Information Technology (Municipal Digital Economy Bureau) announced the evaluation results of the fourth batch of innovative small and medium-sized enterprises in Hangzhou for 2024. Hangzhou Conlead Pharmaceutical successfully won the title of "Hangzhou Innovative Small and Medium-Sized Enterprise".

Founded in 2022, Hangzhou Conlead Pharmaceutical is a joint venture established by Leadingpharm , a dual-listed company, and Hainan Huluwa Pharmaceutical. With a registered capital of 50 million yuan, it is committed to building the largest professional children's drug research and development platform in China. The company is located in Jihua Innovation Industrial Park, Xiaoshan District, Hangzhou, with a 3,000-square-meter research and development laboratory. It focuses on high-end complex preparations, with improved new drugs and children's drugs as the core, and has built technical platforms such as oral dissolving films, orally disintegrating tablets, special oral liquids, and special excipients. Relying on a professional technical team, rich experience in research and development and registration applications, and a sound quality management system, it can provide high-quality technical services such as drug research and development and registration applications for domestic and foreign pharmaceutical enterprises.

At present, with the support and collaboration of Leadingpharm 's industry technical experts and research and development teams, Conlead has successfully carried out research and development work on more than 30 products, among which nearly 10 products have obtained clinical implied licenses, applied for 13 patents independently, and has successively won honors such as "Zhejiang Provincial Science and Technology-Based Small and Medium-Sized Enterprise" and "Hangzhou High-Tech Research and Development Center".

The award of "Hangzhou Innovative Small and Medium-Sized Enterprise" is not only an affirmation of Conlead's efforts in professional construction, innovative practice, and development potential, but also an incentive for it to accelerate the transformation of innovative achievements. In the future, Conlead will actively cooperate with influential domestic and foreign enterprises, research institutions, and scientific research institutes, accelerate the introduction and transformation of technologies and products, fill the gap in high-end pediatric drug research and development in Hangzhou, and help Hangzhou's pharmaceutical industry cluster become a world-class pharmaceutical research and development highland.

-END-

转载声明：未经本网或本网权利人授权，不得转载、摘编或利用其他方式使用上述作品。已经本网或本网权利人授权使用作品的，应在授权范围内使用，并注明“来源：新领先医药科技”。

Back

Previous Next

News

Good Start for Work | Conlead Pharmaceutical Awarded Title of "Hangzhou Innovative Small and Medium-Sized Enterprise"

Recommend